Trends in prostate carcinoma incidence in Connecticut (1988-1994) by age and race

Cancer

Volumn 79, Issue 1, 1997, Pages 99-103

  Polednak, Anthony P ^a  

^a Connecticut Dept of Public Health ^*  (United States)

Author keywords

African Americans; incidence; prostate carcinoma; prostate specific antigen; race; screening

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE CARCINOMA; RACE DIFFERENCE; UNITED STATES; AFRICAN AMERICAN; AGE DISTRIBUTION; CAUCASIAN; ETHNOLOGY; INCIDENCE; MIDDLE AGED; PROSTATE TUMOR; STATISTICS;

AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; CONNECTICUT; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 0030635849     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19970101)79:1<99::aid-cncr14>3.0.co;2-1     Document Type: Article

References (16)

1. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1992: Tables and graphs. Bethesda (MD): National Cancer Institute, 1995. NIH Pub No. 96-2789.
2. Stephenson RA, Smart CR, Mineau GP, James BC, Janerich DT, Dibble RL. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence-Data from the Utah Cancer Registry. Cancer 1996;77:1342-8.
3. Gilliland FD, Welsh DJ, Hoffman RM, Key CR. Rapid rise and subsequent decline in prostate cancer incidence rates for New Mexico, 1989-93. Cancer Epidemiol Biomarkers Prev 1995;4:797-800.
4. Shambaugh E. State bite: accuracy of SEER data. J Natl Cancer Inst 1991;83:1369.
5. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the NCI. Cancer 1995;76:2343-50.
6. Blustein J. The reliability of racial classifications in hospital discharge abstract data. Am J Public Health 1994;84:1018-21.
7. Lilienfeld AM, Lilienfeld DE. Poundations of epidemiology. New York: Oxford University Press, 1980: 353.
8. Polednak AP, Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostate cancer in Connecticut. Cancer 1992;70:2152-8.
9. Potosky A, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-52.
10. Shambaugh EM, Ries LAG, Young JJL, Kruse MA. SEER Extent of Disease 1988 Codes and Coding Instructions. Rockville MD: National Cancer Institute, 1992.
11. Catalona WJ, Smith DS, Basler JW. Detection of organ-confined prostate cancer is increased through prostate specific antigen-based screening. JAMA 1993;270:948-54.
12. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 1993;269:2950-8.
13. Catalona WJ. Screening for early detection of prostate cancer. Lancet 1996;347:1629.
14. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27.
15. Severson RK, Montie JE, Porter AT, Demers RY. Recent trends in incidence and treatment of prostate cancer among elderly men. J Natl Cancer Inst 1995;87:532-4.
16. Cancer in Utah 1966-1990. Salt Lake City UT: Utah Cancer Registry, 1992.